Suppr超能文献

2例B细胞急性淋巴细胞白血病的临床、细胞遗传学及免疫学研究。日本报道的B细胞急性淋巴细胞白血病与伯基特淋巴瘤的比较

[Clinical, cytogenetic and immunological studies of 2 cases with B-cell acute lymphocytic leukemia. Comparison between B-ALL and Burkitt's lymphoma reported in Japan].

作者信息

Tokioka T, Shimamoto Y, Suga K, Sueoka E, Matuzaki M, Ono K, Sano M, Nagumo F, Yamaguchi M

机构信息

Department of Internal Medicine, Saga Medical School.

出版信息

Rinsho Ketsueki. 1990 Jan;31(1):121-6.

PMID:2107343
Abstract

Two patients with acute lymphocytic leukemia of B-cell phenotype (B-ALL) are described. They were 77-year-old female and 34-year-old male. One patient presented with marked splenomegaly, and the other with rupture of spleen on admission. Leukemic morphology revealed a typical L3 profile by FAB classification system in both cases. Immunologic analysis showed the presence of surface immunoglobulins in both cases, and one phenotype was IgM kappa, whereas the other was IgG kappa. Cytogenetic study revealed the typical translocations (8; 14) in both cases. Following chemotherapy, complete remission was achieved in one case, but the other died 36 days after admission. Including our two cases, we studied 12 cases of B-ALL and 77 cases of Burkitt's lymphoma reported in Japan, investigating the clinical prognosis as well as the biological features. We concluded that there are no significant difference of survival between B-ALL and Burkitt's lymphoma. We estimated it is due to oncogenesis from the same original cell in despite of the difference in main tumor site between two diseases.

摘要

本文描述了两名B细胞表型急性淋巴细胞白血病(B-ALL)患者。他们分别是77岁女性和34岁男性。一名患者入院时表现为明显的脾肿大,另一名患者入院时脾脏破裂。白血病形态学在两例中均通过FAB分类系统显示典型的L3型。免疫分析显示两例均存在表面免疫球蛋白,其中一例表型为IgM κ,另一例为IgG κ。细胞遗传学研究显示两例均有典型的(8;14)易位。化疗后,一例实现完全缓解,但另一例在入院36天后死亡。包括我们的两例在内,我们研究了日本报道的12例B-ALL和77例伯基特淋巴瘤病例,调查了临床预后和生物学特征。我们得出结论,B-ALL和伯基特淋巴瘤的生存率无显著差异。我们估计这是由于尽管两种疾病的主要肿瘤部位不同,但它们起源于相同的原始细胞。

相似文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验